COVID-19:Chugai 扩大了抗体鸡尾酒疗法的适应症:Lonapreve™

Vaccine, flu, medical service, Pharmaceutical

Shionogi:开始电晕口服药物的商业化生产:年底前批准申请

flu, Drugs, Pharmaceutical

京都大学:用 iPS 细胞重现顽固性 ALS:治疗药物“博舒替尼”

disease, IPS, Medical science

COVID-19:Shionogi,电晕药物的最终临床试验:S-217622

flu, Drugs, Pharmaceutical

穆斯林在东京清真寺接受食物捐赠

assistance, flu, Medical care

Posts navigation